Gaines Das R E, Rose M, Zanelli J M
Division of Informatics, WHO International Laboratory for Biological Standards, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.
J Reprod Fertil. 1992 Nov;96(2):803-14. doi: 10.1530/jrf.0.0960803.
A lyophilized preparation of inhibin from porcine ovarian follicular fluid, ampoule code 86/690, was made internationally available as a research standard for in vitro bioassays in 1987. A study involving ten participants in eight countries assessed the stability and suitability of this research standard to serve as an international standard. Each of the participants used in vitro assays, the majority of which depended upon the inhibition of release of follicle-stimulating hormone from dispersed rat anterior pituitary cells. The research standard 86/690 was compared with coded ampoules of 86/690 stored under conditions of accelerated thermal degradation and with inhibins from different species. Intra- and interlaboratory variation for estimates of potency of a coded duplicate ampoule of the research standard provided the basis for comparisons of non-identical inhibins, but the fourfold variability of potency estimates for identical ampoules was such that no conclusions about the differences seen for non-identical inhibins could be made. Predictions of stability from consensus estimates of potency of ampoules that have undergone accelerated thermal degradation indicated that the research standard had satisfactory stability. On the basis of this study, the research standard 86/690 was deemed sufficiently stable and suitable to serve as a standard for in vitro bioassays and was established by the World Health Organization Expert Committee on Biological Standardization as the First International Standard for Porcine Inhibin. The possible presence, in biological extracts (standard or sample), of other bioactive proteins, such as activin and follistatin, complicates the quantitative interpretation of bioassay data. A standard of highly purified human inhibin is now required as a standard for immunoassays used for clinical research purposes; sufficient quantities of recombinant human inhibins have recently been donated for ampouling and evaluation by bio- and immunoassay in the subsequent phase of the standardization of inhibins.
1987年,一种来自猪卵巢卵泡液的抑制素冻干制剂(安瓿编号86/690)作为体外生物测定的研究标准在国际上可用。一项涉及八个国家十名参与者的研究评估了该研究标准作为国际标准的稳定性和适用性。每位参与者都使用了体外测定法,其中大多数依赖于抑制分散的大鼠垂体前叶细胞释放促卵泡激素。将研究标准86/690与在加速热降解条件下储存的86/690编码安瓿以及来自不同物种的抑制素进行了比较。对该研究标准编码重复安瓿效力估计的实验室内和实验室间变异为比较不同的抑制素提供了基础,但相同安瓿效力估计的四倍变异性使得无法就不同抑制素之间的差异得出结论。对经过加速热降解的安瓿效力的共识估计得出的稳定性预测表明,该研究标准具有令人满意的稳定性。基于这项研究,研究标准86/690被认为足够稳定且适合作为体外生物测定的标准,并被世界卫生组织生物标准化专家委员会确立为猪抑制素的第一国际标准。生物提取物(标准品或样品)中可能存在的其他生物活性蛋白,如激活素和卵泡抑素,使生物测定数据的定量解释变得复杂。现在需要一种高度纯化的人抑制素标准品作为用于临床研究目的的免疫测定的标准;最近已捐赠了足够数量的重组人抑制素,用于在抑制素标准化后续阶段进行安瓿包装和生物测定及免疫测定评估。